Quest Diagnostics (DGX) Other Non-Current Liabilities (2009 - 2026)

Quest Diagnostics (DGX) has 18 years of Other Non-Current Liabilities data on file, last reported at $1.0 billion in Q1 2026.

• Quarterly Other Non-Current Liabilities rose 11.45% year-over-year to $1.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 billion (up 11.45% YoY) and the FY2025 annual result came in at $957.0 million, up 2.03% from the prior year.
• Other Non-Current Liabilities grew to $1.0 billion in Q1 2026 per DGX's latest filing, from $957.0 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $1.0 billion in Q1 2026, with the low at $6.0 million in Q2 2024.
• Average Other Non-Current Liabilities over 5 years is $772.7 million, with a median of $874.0 million recorded in 2023.
• Year-over-year, Other Non-Current Liabilities plunged 93.18% in 2024 and jumped 14733.33% in 2025.
• Quest Diagnostics' Other Non-Current Liabilities stood at $812.0 million in 2022, then rose by 7.88% to $876.0 million in 2023, then advanced by 7.08% to $938.0 million in 2024, then grew by 2.03% to $957.0 million in 2025, then increased by 6.79% to $1.0 billion in 2026.
• Business Quant data shows DGX's Other Non-Current Liabilities at $1.0 billion in Q1 2026, $957.0 million in Q4 2025, and $982.0 million in Q3 2025.